Patents by Inventor Araba Adjei

Araba Adjei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8048662
    Abstract: Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to cancer also are described.
    Type: Grant
    Filed: April 5, 2011
    Date of Patent: November 1, 2011
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Araba A. Adjei, Eric D. Wieben, Richard M. Weinshilboum, Bianca A. Thomae
  • Publication number: 20110244547
    Abstract: Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to cancer also are described.
    Type: Application
    Filed: April 5, 2011
    Publication date: October 6, 2011
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Araba A. Adjei, Eric D. Wieben, Richard M. Weinshilboum, Bianca A. Thomae
  • Patent number: 7943355
    Abstract: Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to cancer also are described.
    Type: Grant
    Filed: August 18, 2010
    Date of Patent: May 17, 2011
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Araba A Adjei, Eric D Wieben, Richard M Weinshilboum, Bianca A Thomae
  • Publication number: 20110014678
    Abstract: Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to cancer also are described.
    Type: Application
    Filed: August 18, 2010
    Publication date: January 20, 2011
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Araba A. Adjei, Eric D. Wieben, Richard M. Weinshilboum, Bianca A. Thomae
  • Patent number: 7803921
    Abstract: Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to cancer also are described.
    Type: Grant
    Filed: September 25, 2007
    Date of Patent: September 28, 2010
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Araba A. Adjei, Eric D. Wieben, Richard M. Weinshilboum, Bianca A. Thomae
  • Patent number: 7674583
    Abstract: Methods are described for determining sulfonator status of a patient and determining dosages of drugs based on copy number of the SULT1A1 gene.
    Type: Grant
    Filed: November 14, 2006
    Date of Patent: March 9, 2010
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Richard M. Weinshilboum, Araba A. Adjei, Scott J. Hebbring, Stephen N. Thibodeau
  • Patent number: 7485711
    Abstract: Isolated CYP19A1 nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as CYP19A1 allozymes. Methods for determining the aromatase status of an individual also are provided, as are methods for determining if a subject is predisposed to certain clinical conditions.
    Type: Grant
    Filed: August 16, 2005
    Date of Patent: February 3, 2009
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Richard M. Weinshilboum, Eric O. Wieben, Oreste Salavaggione, Araba A. Adjei, Linda Pelleymounter, Josefa Coronel, Liewei Wang, Bruce Eckloff, Daniel Schaid, Cynthia X. Ma
  • Publication number: 20080182326
    Abstract: Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to cancer also are described.
    Type: Application
    Filed: September 25, 2007
    Publication date: July 31, 2008
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Araba A. Adjei, Eric D. Wieben, Richard M. Weinshilboum, Bianca A. Thomae
  • Patent number: 7288641
    Abstract: Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to cancer also are described.
    Type: Grant
    Filed: January 30, 2003
    Date of Patent: October 30, 2007
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Araba A. Adjei, Eric D. Wieben, Richard M. Weinshilboum, Bianca A. Thomae
  • Publication number: 20070178493
    Abstract: Methods are described for determining sulfonator status of a patient and determining dosages of drugs based on copy number of the SULT1A1 gene.
    Type: Application
    Filed: November 14, 2006
    Publication date: August 2, 2007
    Inventors: Richard Weinshilboum, Araba Adjei, Scott Hebbring, Stephen Thibodeau
  • Publication number: 20070134675
    Abstract: Methods are described for determining sulfonator status of a patient and determining dosages of drugs based on copy number of the SULT1A1 gene.
    Type: Application
    Filed: December 8, 2005
    Publication date: June 14, 2007
    Inventors: Scott Hebbring, Stephen Thibodeau, Araba Adjei, Richard Weinshilboum
  • Publication number: 20070037177
    Abstract: Isolated CYP19A1 nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as CYP19A1 allozymes. Methods for determining the aromatase status of an individual also are provided, as are methods for determining if a subject is predisposed to certain clinical conditions.
    Type: Application
    Filed: August 16, 2005
    Publication date: February 15, 2007
    Inventors: Richard Weinshilboum, Eric Wieben, Oreste Salavaggione, Araba Adjei, Linda Pelleymounter, Josefa Coronel, Liewei Wang, Bruce Eckloff, Daniel Schaid, Cynthia Ma